170
Participants
Start Date
July 29, 2022
Primary Completion Date
February 28, 2024
Study Completion Date
September 30, 2024
Connettivina BIO cream and gauze
Connettivina Bio cream and gauze-pad efficacy and tolerability will be evaluated in the management of acute or chronic wounds of different etiology, according to instruction for use. Only one wound per patient will be considered for the treatment according to the study protocol. The schedule treatment will consist on a daily medication changes, according to the instruction for use and the clinical practice, for a maximum of 7 Visits.
NOT_YET_RECRUITING
Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI) - SC (UCO), Trieste
NOT_YET_RECRUITING
Centro Grandi Ustionati OSPEDALE BUFALINI DI CESENA - (FC), Cesena
RECRUITING
AOU Ospedali Riuniti SOD-Clinica di Chirurgia Plastica e Ricostruttiva, Ancona
Lead Sponsor
Fidia Farmaceutici s.p.a.
INDUSTRY